Tesla is back on top in Cathie Wood's flagship ARK ETF as the famed money manager shakes up her largest holdings
Cathie Wood's ARK Invest sold nearly $42 million of Exact Sciences shares in the past week, pushing the medical diagnostic company from its perch as the fund's top holding and replacing it with an old favorite—Tesla.
Tesla has surged more than 22% in the past five days and is on pace for its largest monthly gain since last summer. Shares of the EV maker were up nearly 11% on Friday, trading around $178. "Thus far, in January, we've seen the strongest orders year-to-date than ever in our history," Musk said on Wednesday."We are currently seeing orders that are almost twice the rate of production."
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Musk scrapped plans to take Tesla private, following Ark boss' wishesMusk says he was heeding Ark boss Cathie Wood's wishes when he scrapped the plan to take Tesla private
Lire la suite »
Tesla Superchargers: everything you need to knowEverything you need to know about Tesla Supercharging: what it is, where you can find them and how much it costs to charge for Tesla and non-Tesla drivers
Lire la suite »
SEC Rejects Ark 21Shares Spot Bitcoin ETF for Second TimeThe U.S. markets regular has rejected a score of ETF applications to invest directly in bitcoin, while approving a number of funds tracking the BTC futures market.
Lire la suite »
Spot Bitcoin (BTC) ETF Application by Ark and 21 Shares Rejected by SECThe SEC has shot down a spot Bitcoin (ETF) exchange-traded fund application from Ark and 21Shares once again
Lire la suite »
SEC once again rejects ARK 21Shares Bitcoin ETF listingThe SEC rejected the listing, saying it lacked sufficient protections against fraud.
Lire la suite »
'The Ark': Watch the First Five Minutes of Dean Devlin's New Sci-Fi SeriesWatch the first five minutes of TheArk, a new sci-fi series from Dean Devlin:
Lire la suite »